MedPath

Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma

Phase 2
Conditions
Sarcoma
Registration Number
NCT00245089
Lead Sponsor
Japan Rhabdomyosarcoma Study Group
Brief Summary

RATIONALE: Drugs used in chemotherapy, such as vincristine, dactinomycin, and cyclophosphamide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells.

PURPOSE: This phase II trial is studying how well giving vincristine, dactinomycin, and cyclophosphamide together works in treating patients with embryonal rhabdomyosarcoma.

Detailed Description

OBJECTIVES:

* Determine the progression-free survival rate in patients with low-risk embryonal rhabdomyosarcoma treated with intensive chemotherapy comprising vincristine, dactinomycin, and cyclophosphamide followed by vincristine and dactinomycin.

OUTLINE: Patients receive vincristine IV, dactinomycin IV, and cyclophosphamide IV on day 1. Treatment repeats every 21 days for 8 courses in the absence of disease progression or unacceptable toxicity. Patients then receive vincristine IV and dactinomycin IV on day 1. Treatment repeats every 3 weeks for 8 courses in the absence of disease progression or unacceptable toxicity.

PROJECTED ACCRUAL: A total of 41 patients will be accrued for this study.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
41
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Disease-free survival at 3 years after study registration
Secondary Outcome Measures
NameTimeMethod
Overall survival at 3 years after study registration
Toxicity by NCI CTC at 3 years after study registration

Trial Locations

Locations (48)

Anjo Kosei Hosptial

🇯🇵

Anjo, Aichi, Japan

Aichi Medical University

🇯🇵

Nagakuti, Aichi, Japan

National Hospital Orgnization Nagoya Medical Center

🇯🇵

Nagoya, Aichi, Japan

Ehime Prefectural Central Hospital

🇯🇵

Matsuyama-shi, Ehime, Japan

National Kyushu Cancer Center

🇯🇵

Fukuoka-shi, Fukuoka, Japan

Kurume University School of Medicine

🇯🇵

Kurume City, Fukuoka, Japan

Gifu Municipal Hospital

🇯🇵

Gifu-shi, Gifu, Japan

Gunma Children's Medical Center

🇯🇵

Seta-gun, Gunma, Japan

National Hospital Organization - Medical Center of Kure

🇯🇵

Kure, Hiroshima, Japan

Sapporo Medical University

🇯🇵

Sapporo, Hokkaido, Japan

Scroll for more (38 remaining)
Anjo Kosei Hosptial
🇯🇵Anjo, Aichi, Japan
© Copyright 2025. All Rights Reserved by MedPath